Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.35M Buy
21,033
+383
+2% +$76K 0.08% 91
2026
Q1
$3.04M Sell
20,650
-180
-0.9% -$26.3K 0.04% 146
2025
Q4
$2.53M Buy
20,830
+1,220
+6% +$143K 0.04% 162
2025
Q3
$2.12M Buy
19,610
+110
+0.6% +$10.3K 0.03% 184
2025
Q2
$1.75M Buy
19,500
+1,480
+8% +$111K 0.03% 218
2025
Q1
$1.23M Buy
18,020
+1,100
+7% +$79.2K 0.02% 254
2024
Q4
$1.07M Buy
16,920
+40
+0.2% +$2.7K 0.02% 270
2024
Q3
$1.31M Buy
16,880
+710
+4% +$55.7K 0.02% 233
2024
Q2
$1.33M Buy
16,170
+1,200
+8% +$88.7K 0.02% 214
2024
Q1
$1.05M Buy
14,970
+2,610
+21% +$168K 0.02% 239
2023
Q4
$718K Buy
12,360
+1,460
+13% +$76K 0.01% 289
2023
Q3
$500K Buy
10,900
+90
+0.8% +$4.32K 0.01% 320
2023
Q2
$524K Buy
10,810
+860
+9% +$35.9K 0.01% 305
2023
Q1
$397K Buy
9,950
+4,610
+86% +$182K 0.01% 346
2022
Q4
$201K Buy
+5,340
New +$186K 0.01% 467

Other funds holding KLAC

Ballentine Partners's KLAC Position: Q2 2026 in Review

Ballentine Partners increased its KLA (KLAC) stake by 1.9% in Q2 2026, buying an estimated $76K and bringing the position to 21,033 shares worth $6.35M. The position accounts for 0.08% of the portfolio, ranked #91.

Ballentine Partners first reported a position in KLAC in Q4 2022 and has held it in 15 quarters since. 2,474 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Ballentine Partners held 21,033 shares of KLA worth $6.35M as of Q2 2026.
  • Ballentine Partners bought 383 KLA shares in Q2 2026, an estimated $76K.
  • KLA made up 0.08% of Ballentine Partners's portfolio in Q2 2026, its #91 holding.
  • Ballentine Partners first reported a position in KLA in Q4 2022 and has held it in 15 quarters since.
  • 2,474 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.